Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin alfa in anemic cancer patients not on chemo/radio
NCT00083434Phase 3Terminated
- Sponsor
- Johnson & Johnson
- Start
- Feb 2004
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anemia comparing Epoetin alfa with Placebo/Control (2 arms). Started Feb 2004; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00083434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083434.